UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051316
Receipt number R000058535
Scientific Title Prospective observational study of colorectal cancer examining diagnosis opportunity and risk factors: CRC-DR study
Date of disclosure of the study information 2023/06/12
Last modified on 2023/08/24 17:38:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective observational study of colorectal cancer examining diagnosis opportunity and risk factors, CRC-DR study

Acronym

CRC-DR study

Scientific Title

Prospective observational study of colorectal cancer examining diagnosis opportunity and risk factors: CRC-DR study

Scientific Title:Acronym

CRC-DR study

Region

Japan


Condition

Condition

colorectal cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To prospectively enroll 1000 colorectal cancer patients from various facilities such as cancer centers, community hospitals, and clinics, and to investigate their history of colonoscopy and fecal occult blood test, and the trigger for detection.

Basic objectives2

Others

Basic objectives -Others

Factors associated with the development of colorectal cancer, such as alcohol consumption, smoking, exercise, family history of diet, marriage, education, and income, will also be investigated to examine their association.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Motivation and Symptoms of Colorectal Cancer Detection in Intramucosal vs. Invasive Cancer

Key secondary outcomes

To explore and evaluate the relationship between past colonoscopy and screening history and the occurrence of colorectal cancer at different levels of progression. We will also include life history, blood sampling data, and social background as risk factors for colorectal cancer to evaluate the relationship with the occurrence of colorectal cancer. In addition, we will conduct an exploratory comprehensive analysis using various items.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients newly diagnosed with colorectal cancer at each facility including referrals
Patients who have given written consent to participate in the research of their own free will
Patients who are 20 years of age or older at the time of consent

Key exclusion criteria

1. Patients with pathologically confirmed colorectal cancer in the past
2. Patients who the principal investigator determines to be unsuitable as subjects or whose consent cannot be obtained.

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Naohisa
Middle name
Last name Yoshida

Organization

Kyoto Prefectural University of Medicine

Division name

Molecular Gastroenterology and Hepatology

Zip code

602-8566

Address

Kajii-cho 465 Kamigyo-ku, Kyoto, Japan

TEL

0752515519

Email

naohisa@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Naohisa
Middle name
Last name Yoshida

Organization

Kyoto Prefectural Univedrsity of Medicine

Division name

Molecular Gastroenterology and Hepatology

Zip code

602-8566

Address

Kajii-cho 465 Kamigyo-ku, Kyoto, Japan

TEL

+81752515519

Homepage URL


Email

naohisa@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University of Medicine

Institute

Department

Personal name

Naohisa Yoshida


Funding Source

Organization

self-procurement

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Osaka International Cancer Center
Sano Hospital
Oda clinic
Ishikawa Gastroenterology Clinic
Japan General Hospital of West Japan Railway Company
Nishizin Hospital
Kyoto Saiseikai Hospital
Ayabe City Hospital
Kyoto First Red Cross Hospital
Otsu City Hospital
Aiseikai Yamashina Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Kyoto prefectural univeristy of medicine

Address

Kajii-cho 465, Kamigyo-ku, Kyoto, Japan

Tel

075-251-5337

Email

rinri@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

1. 大阪国際がんセンター(大阪府)
2. 医療法人 薫風会佐野病院(兵庫県)
3.尾田胃腸内科・内科(熊本県)
4. 医療法人いちょう会石川消化器内科(大阪府)
5. JR大阪鉄道病院(大阪府)
6. 西陣病院(京都府)
7. 済生会京都府病院(京都府)
8. 綾部市立病院(京都府)
9. 京都第一赤十字病院(京都府)
10. 市立大津市民病院(滋賀県)
11. 愛生会山科病院(京都府)


Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 01 Month 01 Day

Date of IRB

2023 Year 05 Month 25 Day

Anticipated trial start date

2023 Year 07 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

N/A


Management information

Registered date

2023 Year 06 Month 10 Day

Last modified on

2023 Year 08 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058535


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name